Psoriatic Arthritis News

PHILADELPHIA — A daily glucocorticoid dose higher than 2.5 mg may lead to irreversible bone mineral density loss regardless of intervention with osteoporosis medications, according to data presented at ACR Convergence 2022.

PHILADELPHIA — Patients who switched from one infliximab biosimilar to another experienced comparable treatment retention rates, according to data presented at ACR Convergence 2022.

Patients with autoimmune diseases may be at higher risk for cardiovascular disease than patients without autoimmune diseases, according to data published in The Lancet.

In patients with autoimmune rheumatic diseases, vaccination against COVID-19 does not appear to correlate with increased flares, regardless of disease status, previous exposure and vaccine type, according to data published in Rheumatology.

SAN DIEGO — Domain-based or treat-to-target approaches can be effective in managing patients with complex psoriatic arthritis and avoiding “just trial and error,” according to a speaker at the Congress of Clinical Rheumatology West.

Among patients with similar psoriatic arthritis disease activity and therapy, women demonstrate higher levels of disease burden than men, according to data published in The Journal of Rheumatology.

Online forums, chatrooms and communities are often able help patients with chronic illness find comfort by connecting with other patients sharing their disease burden.

MILAN — Long-term treatment with risankizumab maintained efficacy in psoriatic arthritis through 100 weeks, according to a study presented at the European Academy of Dermatology and Venereology Congress.

Psoriasis is not only a disease that impacts patients physically, with scars and red patchy skin, but it also impacts patients emotionally. Patients’ mental health often suffer due to the anxieties of living with the condition.

The word “gaslighting” has taken on a life of its own in recent years, being used in the context of interpersonal relationships, political discourse and online chatter alike.